Does an implantable cardioverter-defibrillator improve overall survival in survivors of ventricular fibrillation or sustained ventricular tachycardia compared to antiarrhythmic drugs?
Survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms (resuscitated from near-fatal ventricular arrhythmias)
Implantable cardioverter-defibrillator
Antiarrhythmic-drug therapy
Overall survivalhard clinical
Implantable cardioverter-defibrillators are superior to antiarrhythmic drugs for increasing overall survival in patients resuscitated from near-fatal ventricular arrhythmias.
Among survivors of ventricular fibrillation or sustained ventricular tachycardia causing severe symptoms, the implantable cardioverter-defibrillator is superior to antiarrhythmic drugs for increasing overall survival.
Building similarity graph...
Analyzing shared references across papers
Loading...
The Antiarrhythmics versus Implantable Defibrillators Investigators
New England Journal of Medicine
Building similarity graph...
Analyzing shared references across papers
Loading...
The Antiarrhythmics versus Implantable Defibrillators Investigators (Thu,) studied this question.
www.synapsesocial.com/papers/69d572c875589c71d767e7ad — DOI: https://doi.org/10.1056/nejm199711273372202
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: